Invention Grant
- Patent Title: Isoquinoline potassium channel inhibitors
- Patent Title (中): 异喹啉钾通道抑制剂
-
Application No.: US10572342Application Date: 2004-09-17
-
Publication No.: US07691879B2Publication Date: 2010-04-06
- Inventor: B. Wesley Trotter , Kausik K. Nanda , Nathan R. Kett , Christopher J. Dinsmore , Gerald S. Ponticello , David A. Claremon
- Applicant: B. Wesley Trotter , Kausik K. Nanda , Nathan R. Kett , Christopher J. Dinsmore , Gerald S. Ponticello , David A. Claremon
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Heidi M. Struse; Mark R. Daniel; Richard S. Parr
- International Application: PCT/US2004/030486 WO 20040917
- International Announcement: WO2005/030130 WO 20050407
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D217/00 ; C07D217/22
Abstract:
The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
Public/Granted literature
- US20060276450A1 Isoquinoline potassium channel inhibitors Public/Granted day:2006-12-07
Information query
